Article info
Case report
The impact of national guidance for anomaly screening and invasive testing: unintended consequences
- Correspondence to Mr Christoph Lees, Department of Fetal Medicine, Rosie Hospital, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 2QQ, UK; christoph.lees{at}imperial.nhs.uk
Citation
The impact of national guidance for anomaly screening and invasive testing: unintended consequences
Publication history
- Received March 14, 2013
- Revised May 28, 2013
- Accepted May 29, 2013
- First published July 5, 2013.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions